Picture of Pure Biosciences logo

PURE — Pure Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapNeutral

PURE Bioscience Q2 net product sales rise, net loss narrows

Overview

US antimicrobial products maker's fiscal Q2 net product sales rose 13% yr/yr

Net loss for fiscal Q2 narrowed slightly

Outlook

Company expects to launch PURE Clean and fulfill pre-orders in fiscal third qtr

Result Drivers

END-USER SALES - Co said Q2 net product sales increase was due to higher sales across its end-user network

Company press release: ID:nBw4hdxCva

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 EPS-$0.01
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Pure Biosciences

See all news